Jefferies analyst Thomas Wei reiterated a Buy rating and $3 price target on Dynavax Technologies (NASDAQ: DVAX) following Q4 results.
This article: 140 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE